Quick Takeaways
- Christine A. Poon has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $13,283,918.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Christine A. Poon
- Location
- New Brunswick, NJ
- Summary
- The estimated net worth of Christine A. Poon is at least $13,283,918 dollars as of 16 Mar 2026. Christine A. Poon is the Director of SHERWIN WILLIAMS CO and owns shares of SHERWIN WILLIAMS CO (SHW) stock worth about $5.06M. Christine A. Poon is the Director of REGENERON PHARMACEUTICALS, INC. and owns shares of REGENERON PHARMACEUTICALS, INC. (REGN) stock worth about $4.03M. Christine A. Poon is the Director of PRUDENTIAL FINANCIAL INC and owns shares of PRUDENTIAL FINANCIAL INC (PRU) stock worth about $3.62M. Christine A. Poon is the Director of NEUROCRINE BIOSCIENCES INC and owns shares of NEUROCRINE BIOSCIENCES INC (NBIX) stock worth about $574.9K.
- Signature
- /s/ Richard J. Baker, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Christine A. Poon and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: SHERWIN WILLIAMS CO ($5,060,011).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Christine A. Poon
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SHW | SHERWIN WILLIAMS CO | Director | $5,060,011 | 04 Apr 2025 | ||
| REGN | REGENERON PHARMACEUTICALS, INC. | Director | $4,028,389 | -$4,252,745 | -51% | 02 Jan 2026 |
| PRU, PFH | PRUDENTIAL FINANCIAL INC | Director | $3,620,649 | 12 Mar 2026 | ||
| NBIX | NEUROCRINE BIOSCIENCES INC | Director | $574,869 | 21 May 2025 |
Insider Transactions Reported by Christine A. Poon:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.